STOCK TITAN

Simulations Plus Announces the University+ Program

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Simulations Plus (NASDAQ: SLP) has launched a new University+ Program offering free access to its modeling and simulation software for one year to students and educators at accredited universities worldwide. This initiative celebrates the company's 25th anniversary and aims to enhance education in Modeling and Simulation (M&S). Eligibility for renewal is available under certain conditions. The program seeks to prepare future scientists for careers in drug development and related fields, fostering academic research and collaboration.

Positive
  • Launch of University+ Program providing free software access to accredited universities enhances educational opportunities.
  • Increased potential talent pool for future scientific positions through the internship and postdoc opportunities.
Negative
  • None.

Free access to Simulations Plus software for accredited universities will accelerate learning and educational pursuits

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the formation of the University+ Program as part of its 25th anniversary celebration.

The University+ Program offers free one-year access to Simulations Plus software to students and educators at accredited universities worldwide and is renewable provided eligibility conditions are met. General terms and conditions, along with the simple and straightforward application form, can be found at our website.

John DiBella, Simulations Plus division president, stated: “Simulations Plus has been a staunch supporter of academic research training and collaborations for over two decades to advance the science of Modeling and Simulation (M&S). The goal of the new University+ Program is to increase M&S education and publications that will promote the next generation of scientists by setting them up today for success tomorrow. By providing accredited universities with free access to the Simulations Plus portfolio of software, we will be able to drive M&S learning and understanding prior to entering the workforce. This program will prepare future scientists for numerous opportunities, including participation in our Internship+ Program to gain further hands-on experience with industry leading M&S tools, funded postdoc opportunities with our company, or full-time employment careers where they can apply model informed drug development (MIDD) skills and methods with Simulations Plus, industry, academia, or government agencies.”

“What better way of celebrating our 25th anniversary than by investing in the next generation of scientists,” added Shawn O’Connor, CEO of Simulations Plus. “Free access to state-of-the-art platforms, with all features enabled, across the divisions of our company will have an immediate and positive impact on academic programs across the globe, increase the talent pool of future scientists, and help contribute to the rapid development of safer, lower cost treatments for patients worldwide.”

About Simulations Plus, Inc.

Serving clients worldwide for 25 years, Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like “believe,” “expect” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.

Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

renee@simulations-plus.com

Hayden IR

Mr. Brian Siegel

346-396-8696

brian@haydenir.com

Source: Simulations Plus, Inc.

FAQ

What is the University+ Program launched by Simulations Plus?

The University+ Program offers free one-year access to Simulations Plus software for accredited universities, promoting education in Modeling and Simulation.

How does the University+ Program benefit Simulations Plus (SLP)?

The program enhances the company's visibility in academia, increases the talent pool, and supports future recruitment efforts.

Is the access to Simulations Plus software renewable for universities?

Yes, access is renewable based on eligibility conditions as outlined by Simulations Plus.

When did Simulations Plus launch the University+ Program?

Simulations Plus launched the University+ Program as part of its 25th anniversary celebration.

What is the goal of the University+ Program from Simulations Plus?

The goal is to drive education and research in Modeling and Simulation, preparing students for successful careers in the industry.

Simulations Plus, Inc.

NASDAQ:SLP

SLP Rankings

SLP Latest News

SLP Stock Data

584.06M
16.45M
18.04%
77.91%
4.93%
Health Information Services
Services-computer Integrated Systems Design
Link
United States of America
LANCASTER